In a phase 1b trial, 20 weeks of cagrilintide 2.4 mg once weekly in combination with semaglutide 2.4 mg once weekly (cagrisema) resulted in up to 17.1% WL compared to 9.5% WL with semaglutide 2.4 mg plus placebo in people with obesity [88]
Britta Reierson , MD, FAAFP, a board-certified family physician and obesity medicine specialist at knownwell, a metabolic health company , cites a national Michigan Medicine survey that shows that up to 60,000 young adults are using GLP-1s on a regular basis, compared to 8,700 a month in 2020
Patients with a body mass index (BMI) over 30, diabetes and/or cardiovascular disease are all patients that could benefit from this treatment, Dr
Lei et al
Thng hiu: Nutricost - M u im: - Hm lng Biotin cao, cung cp ti 10.000 mcg/vin - Cng thc ton din 3 trong 1 (Biotin - Folate - Collagen) - nhng dng cht cc k cn thit cho n gii